Currently, out of the existing stock ratings of Chad Mabry - 32 which are a Buy (96.97%), 1 which are a Hold (3.03%)

Chad Mabry

Work Performance Price Targets & Ratings Chart

Analyst Chad Mabry works at B. RILEY and is covering Energy, Healthcare sectors with 66 price targets and ratings displayed on 9 stocks. Previously, Chad Mabry worked at MLV.

Chad Mabry's average stock forecast success ratio is 42.59% with an average time for price targets to be met of 383.56 days.

Most recent stock forecast was given on ALT, Altimmune at 07-Sep-2021.

Wall Street Analyst Chad Mabry

Analyst best performing recommendations are on QEP.
The best stock recommendation documented was for QEP at 7/21/2016. The price target of $19 was fulfilled within 25 days with a profit of $2.06 (12.16%) receiving and performance score of 4.86.

Average potential price target upside

CPE Callon Petroleum Company CRZO ESTE Earthstone Energy GTBP GT Biopharma INMB INmune Bio ALT Altimmune MTDR Matador Resources Company QEP WPX

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

44

$12.8 (41.03%)

53

5 days ago

0/8 (0%)

$46.42 (68.86%)

Buy

42

$10.8 (34.62%)

50

13 days ago

2/11 (18.18%)

$15.79 (43.90%)

29

Buy

63

$31.8 (101.92%)

59

2 months 17 days ago

1/6 (16.67%)

$20.59 (53.42%)

7

Hold

45

$13.8 (44.23%)

40

3 months 19 days ago

4/5 (80%)

$4.68 (13.12%)

63

Buy

48

$16.8 (53.85%)

55

3 months 28 days ago

8/16 (50%)

$11 (39.23%)

39

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Chad Mabry?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart